PAUL G HARCH MD Hyperbaric Oxygen Therapy employs pressurized chambers in which the patient undergoes a series of “dives” in pure oxygen at varying depths of pressure, which is measured in atmospheres. Patients usually undergo 5, 1-hour dives each week for 8 weeks in the first round of treatment. After the first round, the physician will determine how many additional dives will be necessary for the patient to achieve the optimal clinical outcome.
Dr. Harch has long been considered a pioneer in hyperbaric medicine research and clinical applications. Author of The Oxygen Revolution, Dr. Harch has written numerous articles on Hyperbaric Oxygen Therapy and has had several writings published in major medical journals. Dr. Harch was responsible for the scientific argument and application to Medicare that resulted in the approval of hyperbaric oxygen treatment of diabetic foot wounds. Based on Dr. Richard Neubauer’s work and in conjunction with Dr. Van Meter he has developed many of the accepted protocols for HBOT in neurological disorders, including chronic traumatic brain injury and Post Traumatic Stress Disorder in our military veterans.
For more information on Dr. Harch and his work in Hyperbaric Oxygen Therapy visit their website call 1-855-GET-HBOT
Further Research from
National Center for Biotechnology Information: Hyperbaric oxygen therapy applied research in traumatic brain injury: from mechanisms to clinical investigation
Veterans Affairs views as of Jan 2015 DoD, VA research again finds hyperbaric oxygen ineffective at treating concussion-related injuries